GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Daan Gene Co Ltd (SZSE:002030) » Definitions » Stock Based Compensation

Daan Gene Co (SZSE:002030) Stock Based Compensation : ¥0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Daan Gene Co Stock Based Compensation?

Daan Gene Co's Stock Based Compensation for the three months ended in Dec. 2024 was ¥0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was ¥0.0 Mil.


Daan Gene Co Stock Based Compensation Historical Data

The historical data trend for Daan Gene Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daan Gene Co Stock Based Compensation Chart

Daan Gene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daan Gene Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daan Gene Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


Daan Gene Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Daan Gene Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Daan Gene Co Business Description

Traded in Other Exchanges
N/A
Address
No.19 Xiangshan Road, Science Park, High & New Technology Development District, Guangdong, Guangzhou, CHN, 510665
Daan Gene Co Ltd is a high-tech enterprise-oriented in molecular diagnostic techniques. It is primarily committed to research and development, production, and service of in-vitro diagnostic products, including qPCR, Sequeacing, TRF, ELISA, and Liquid-Based Cytology diagnostic kits and equipment. Geographically, tahe group operates in China.
Executives
Zhou Xin Yu Directors, executives
He Yun Shao Director
Huang Ru Hui Supervisors
Cheng Gang Directors, executives
Xu Qing Supervisors
He Li Xin Supervisors

Daan Gene Co Headlines

No Headlines